JSML - ETF AI Analysis

Top Page

Janus Henderson Small Cap Growth Alpha ETF (JSML)

Rating:71Outperform

Price Target:―

The Janus Henderson Small Cap Growth Alpha ETF (JSML) has an overall rating that reflects a mix of strong performers and some weaker holdings. Catalyst Pharma stands out as a key contributor, driven by its solid financial health, raised revenue guidance, and strategic initiatives that position it well for growth. On the other hand, Workiva's high leverage and negative equity weigh down the fund's rating. A notable risk is the ETF's exposure to smaller companies, which can be more volatile and sensitive to market conditions.

Positive Factors

Solid Recent Performance

The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.

Strong Top Holdings Contribution

Most of the top 10 holdings have delivered strong or steady performance so far this year, helping support the fund’s overall returns.

Focused Growth Sectors

Large weights in Health Care and Technology give the fund exposure to sectors that often drive growth in the small-cap space.

Negative Factors

Single-Country Concentration

With almost all assets invested in U.S. companies, the fund offers little geographic diversification and is highly tied to the U.S. market.

Sector Concentration Risk

Heavy exposure to just a few sectors, especially Health Care and Technology, means the fund could be hit hard if those areas weaken.

Moderate Expense Ratio

The fund’s expense ratio is not especially low, so fees may take a noticeable bite out of returns compared with the cheapest ETFs.

JSML vs. SPDR S&P 500 ETF (SPY)

AUM299.11M

RegionNorth America

Expense Ratio0.30%

Beta1.06

IssuerJanus Henderson

Inception DateFeb 25, 2016

Dividend Yield0.89%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume63,425

30 Day Avg. Volume29,908

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

93.04

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering120

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

JSML Summary

JSML, the Janus Henderson Small Cap Growth Alpha ETF, focuses on fast-growing smaller U.S. companies rather than tracking a set index. It invests across many sectors, with a lot in health care and technology, and holds names like Bloom Energy and Catalyst Pharma. Someone might consider JSML if they want growth potential and diversification among many small companies that could become future leaders. However, this ETF is concentrated in smaller, growth-focused stocks, which can be more volatile and can go up and down more sharply than the overall market.

How much will it cost me?The Janus Henderson Small Cap Growth Alpha ETF (JSML) has an expense ratio of 0.30%, meaning you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average because the fund is actively managed, focusing on selecting high-growth small-cap companies rather than tracking a passive index.

What would affect this ETF?JSML's focus on U.S. small-cap growth companies in sectors like technology, health care, and industrials positions it to benefit from innovation, economic expansion, and increased consumer demand. However, small-cap stocks are more sensitive to economic downturns, interest rate hikes, and regulatory changes, which could negatively impact growth-focused firms. Investors should also consider the higher volatility associated with small-cap investments.

JSML Top 10 Holdings

JSML is leaning into U.S. small-cap growth with a clear tilt toward tech and industrial innovators. Bloom Energy has been the star of the show lately, powering returns with a strong, rising trend, while Credo Technology and Sanmina add steady tech momentum. Argan and Cactus are also pulling their weight, giving the fund an industrial backbone. On the softer side, Enova and InterDigital have shown more mixed, sometimes lagging action, occasionally putting a small drag on performance. Overall, it’s a U.S.-focused, growth-heavy portfolio built around emerging leaders.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
BE	Bloom Energy	2.30%	$6.89M	$39.12B	565.43%	62 Neutral
CRDO	Credo Technology Group Holding Ltd	1.94%	$5.81M	$23.42B	100.71%	77 Outperform
WHD	Cactus	1.94%	$5.80M	$4.38B	-7.47%	77 Outperform
ENVA	Enova International	1.93%	$5.79M	$3.94B	45.21%	71 Outperform
ATMU	Atmus Filtration Technologies, Inc.	1.90%	$5.69M	$4.62B	35.20%	78 Outperform
IDCC	InterDigital	1.88%	$5.61M	$8.55B	79.11%	76 Outperform
AGX	Argan	1.87%	$5.60M	$4.98B	159.70%	73 Outperform
RHP	Ryman	1.85%	$5.54M	$5.89B	-10.39%	66 Neutral
CPRX	Catalyst Pharma	1.74%	$5.20M	$2.97B	5.99%	83 Outperform
NXT	Nextpower Inc	1.73%	$5.17M	$17.80B	136.95%	78 Outperform

JSML Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

75.08

Positive

100DMA

74.83

Positive

200DMA

70.39

Positive

Market Momentum

MACD

0.67

Positive

RSI

54.91

Neutral

STOCH

30.63

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JSML, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 76.85, equal to the 50-day MA of 75.08, and equal to the 200-day MA of 70.39, indicating a bullish trend. The MACD of 0.67 indicates Positive momentum. The RSI at 54.91 is Neutral, neither overbought nor oversold. The STOCH value of 30.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JSML.

JSML Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
JSML	―	―	$299.11M	0.30%	―
OSCV	―	―	$671.53M	0.79%	―
SEIS	―	―	$416.38M	0.55%	―
TSCV	―	―	$159.25M	0.60%	―
SCDV	―	―	$133.57M	0.70%	―
FSCC	―	―	$118.81M	0.36%	―

Performance Comparison

JSML

Janus Henderson Small Cap Growth Alpha ETF

77.22

9.03

13.24%

OSCV

Opus Small Cap Value ETF

―

SEIS

SEI Select Small Cap ETF

―

TSCV

Thrivent Small Cap Value ETF

―

SCDV

Bahl & Gaynor Small Cap Dividend ETF

―

FSCC

Federated Hermes MDT Small Cap Core ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents